Newsgroups Main » Newsgroups Directory » Science and Technology » Medicine

Lyme disease ( sci.med.diseases.lyme )
spacer NewsDemon Usenet 2021 Access
 
From [email protected] Tue Mar  7 16:37:05 1995 Path: uunet!bounce-back From: Linda Palund <[email protected]> Newsgroups: news.announce.newgroups,news.groups,alt.med.fibromyalgia,alt.support.arthritis,misc.health.arthritis,sci.med,sci.med.immunology Subject: RFD: misc.health.lyme-disease Followup-To: news.groups Date: 7 Mar 1995 15:34:58 -0500 Organization: monkeypa.demon.co.uk Lines: 112 Sender: [email protected] Approved: [email protected] Message-ID: <[email protected]> NNTP-Posting-Host: rodan.uu.net Xref: gs2.UU.NET news.announce.newgroups:6345 news.groups:137985 alt.med.fibromyalgia:15690 alt.support.arthritis:3185 misc.health.arthritis:880 sci.med:119451 sci.med.immunology:1090                          REQUEST FOR DISCUSSION  PROPOSED GROUP:  misc.health.lyme-disease        Lyme Disease and related issues.                                 Unmoderated.   This is a formal Request For Discussion concerning the creation of an unmoderated newsgroup to be called misc.health.lyme-disease.  This RFD is being posted in accordance with the Guidelines for Newgroup Creation.  Its language is based on previously submitted RFDs.  Its format follows a suggestion by David C. Lawrence, the moderator of news.announce.newgroups.   RATIONALE:  There is currently no discussion group for the many persons suffering >from Lyme Disease, a devastating illness which is prevalent all over the world, between the same latitudes and wherever the disease carrying tick thrives.  This disease has become a problem from North America to Slovakia and beyond, with symptoms as varied as the terrain. Patients are often left isolated by their debilitating symptoms in quite rural locations.  Because their activities often take them into areas where the tick is found, Lyme Disease is particularly common among teenagers and young children.  Fortunately, many of these young people have access to a computer, usually through their school. Both young patients and adult sufferers may never actually meet another Lyme Disease patient face to face, and being able to communicate via a Lyme Disease newsgroup could be invaluable help in easing their fears and giving them the support they need, for although there are Lyme Disease support groups in various geographic locations, the severe limitations of the varied symptoms experienced by patients make it often impossible for them to physically attend these groups. This proposed newsgroup would give housebound patients a much needed forum to discuss their problems,symptoms, fears and victories.   MAILING LISTS:  There currently exists a Lyme Disease Mailing List, LymeNet, which publishes an informational newsletter to its 1200 direct subscribers, as well as being gated to the sci.med newsgroup.  In addition, I am aware that many people copy the LymeNet Newsletter and redistribute it as per the reprint agreement.  LymeNet is useful for the dissemination of new information about Lyme disease as it is made available and will definitely be useful as a resource for the proposed discussion group, but it is not able to offer the give and take that an open discussion group can offer and the publishers of LymeNet have no plans to make such a discussion group available to all sites.  I am planning to ask the publishers to gateway the LymeNet Mailing List to misc.health.lyme-disease.   CHARTER:  The proposed newsgroup would be intended for discussion about the many different aspects of Lyme Disease as experienced by patients, their caregivers, friends and family members, doctors and other medical professionals, or anyone affected by or involved with Lyme Disease.  Anyone with an interest in Lyme Disease is free to post, including the medical and scientific community, but this newsgroup is mainly interested in fostering communication between Lyme Disease sufferers >from all parts of the globe, rather than purely medical or scientific debate, although these discussions will be welcome for informational purposes.  The following are examples of possible posting topics:  - symptoms and questions arising from the onset of new symptoms - treatments and therapies, both conventional and alternative - emotions, including fears and anxieties caused by this illness - social issues regarding this illness - problems in the medical community confronting Lyme Disease - new information and resources available about this illness - related practical problems and solutions  Commercial advertisements may NOT be posted to this proposed group.   PROCEDURE:  After a discussion period of 21-30 days, and if there are no overwhelming objections to the proposed group, there will be a Call For Votes (CFV) posted to the same groups as this RFD.  The voting period will be at least 21 days.  If the group passes by receiving a 2/3rds majority of YES votes to all valid YES & NO votes as well as 100 more YES votes than NO votes, it will be created.   DISTRIBUTION:  This RFD is being posted to the following relevant newsgroups:    news.announce.newgroups, news.groups   alt.med.fibromyalgia, alt.support.arthritis, misc.health.arthritis   sci.med, sci.med.immunology  Subsequent discussion should take place in news.groups, or by private e-mail to the proponent.  The headers of this message are set to direct standard Usenet software to do this automatically. Please send a copy of every followup article to the proponent as well to avoid being accidentally ignored.   Proposed by:    Linda Palund     <[email protected]> Mentor:         Taneli Huuskonen <[email protected]>  From [email protected] Thu May 25 18:47:02 1995 Path: uunet!bounce-back From: Linda Palund <[email protected]> Newsgroups: news.announce.newgroups,news.groups,alt.med.fibromyalgia,alt.support.arthritis,misc.health.arthritis,sci.med,sci.med.immunology Subject: 2nd RFD: sci.med.diseases.lyme Date: 23 May 1995 15:33:44 -0400 Organization: Monkeypaw Productions Lines: 133 Sender: [email protected] Approved: [email protected] Message-ID: <[email protected]> NNTP-Posting-Host: rodan.uu.net Folloup-To: news.groups Xref: gs2.UU.NET news.announce.newgroups:6874 news.groups:150933 alt.med.fibromyalgia:23106 alt.support.arthritis:4144 misc.health.arthritis:1641 sci.med:128965 sci.med.immunology:1650                       REQUEST FOR DISCUSSION (RFD)                unmoderated group sci.med.diseases.lyme     changed proposal from unmoderated group misc.health.lyme-disease  Newsgroups line: sci.med.diseases.lyme	Lyme Disease and related issues.   This is a formal Request For Discussion concerning the creation of an unmoderated newsgroup to be called sci.med.diseases.lyme.  This is the same group that was recently proposed under the title of misc.health.lyme-disease.  After a long discussion period it was decided by consensus that the misc.health category was not the best choice for a Lyme Disease discussion group for the following reasons: Many of the respondents were unable to access the misc category at their sites.  In addition, the consensus felt that the sci.med category would better serve their desires to have a serious as well as informative and accessible forum for discussion and would encourage the participation of the medical and scientific community.  Therefore we are posting the RFD again under the new name of sci.med.diseases.lyme.  The first paragraph of the Charter has been amended to include anyone who has an interest in educating themselves about the symptoms, treatment, and prevention of Lyme Disease. The second paragraph of the Charter has been changed to reflect the wishes of the consensus to encourage participation by the medical and scientific community.  Other changes that have been made are inessential corrections in wording to clarify the language of the RFD.   This RFD is being posted in accordance with the Guidelines for Newsgroup Creation.  Its language is based on previously submitted RFDs.  Its format follows a suggestion by David C. Lawrence, the moderator of news.announce.newgroups.   RATIONALE:  There is currently no discussion group for the many persons suffering from Lyme Disease, a devastating illness which has become a problem from North America to Slovakia or wherever the disease carrying tick thrives. The symptoms are as varied as the terrain and patients are often left isolated by these debilitating symptoms in quite rural locations.  Although there are Lyme Disease support groups in various geographic locations, the severe limitations of the varied symptoms experienced by patients make it often impossible for them to physically attend these groups. This proposed newsgroup would give housebound patients a much needed forum to discuss their problems, symptoms, fears and victories. Lyme Disease is particularly common among teenagers and young children because their activities often take them into areas where the tick is found. Fortunately, many of these young people have access to a computer, usually through their school. Both young patients and adult sufferers may never actually meet another Lyme Disease patient face to face, and being able to communicate via a Lyme Disease newsgroup could be invaluable help in easing their fears and giving them the support they need.  MAILING LISTS:  There currently exists a Lyme Disease Mailing List, LymeNet, which publishes an informational newsletter to its 1200 direct subscribers, as well as being gated to the sci.med newsgroup.  In addition, I am aware that many people copy the LymeNet Newsletter and redistribute it as per the reprint agreement.  LymeNet is useful for the dissemination of new information about Lyme Disease as it is made available and will definitely be useful as a resource for the proposed discussion group, however it is not able to offer the give and take that an open discussion group can offer and the publishers of LymeNet have no plans to make such a discussion group available to all sites.  We are planning to gateway the LymeNet Mailing List to sci.med.diseases.lyme.   CHARTER:  The proposed newsgroup is intended for discussion about the many different aspects of Lyme Disease as experienced by patients, their caregivers, friends and family members, doctors and other medical professionals, or anyone affected by or involved with Lyme Disease, as well as those who wish to learn about its symptoms, latest treatment options and its prevention.  Anyone with an interest in Lyme Disease is free to post, including the medical and scientific community, as this newsgroup is interested both in fostering communication between Lyme Disease sufferers from all parts of the globe, as well as providing an open forum for the exchange of medical and scientific information which can be useful to all participants.  Above all, we wish to encourage a supportive and open atmosphere for the free exchange of opinions and information.  The following are examples of possible posting topics:  - questions regarding any aspect of Lyme Disease - symptoms and problems arising from the onset of new symptoms - treatments and therapies, both conventional and alternative - emotions, including fears and anxieties caused by this illness  - social issues regarding this illness - problems in the medical community in regard to Lyme Disease - new information and resources available about the disease - related practical problems or solutions - Lyme Disease research findings  Commercial advertisements may NOT be posted to this proposed group.   PROCEDURE:  If there are no overwhelming objections to the proposed group, there will be a Call For Votes (CFV) posted to the same groups as this RFD.  The voting period will be at least 21 days.  If the group passes by receiving a 2/3rds majority of YES votes to all valid YES & NO votes as well as 100 more YES votes than NO votes, it will be created.   DISTRIBUTION:  This RFD is being posted to the following relevant newsgroups:          news.announce.newgroups, news.groups         alt.med.fibromyalgia         alt.support.arthritis, misc.health.arthritis         sci.med, sci.med.immunology   Subsequent discussion should take place in news.groups only, not in other above-mentioned groups.  The Followup-To: header is set accordingly.  Proposed by:    Linda Palund     <[email protected]> Mentor:         Taneli Huuskonen <[email protected]>  From [email protected] Wed Jun 21 16:42:56 1995 Status: RO Path: uunet!bounce-back From: [email protected] (Warren Lavallee) Newsgroups: news.announce.newgroups,news.groups,sci.med,sci.med.immunology,alt.med.fibromyalgia,alt.support.arthritis,misc.health.arthritis,bionet.microbiology,sci.bio.microbiology Subject: CFV: sci.med.diseases.lyme Followup-To: poster Date: 21 Jun 1995 01:20:48 -0400 Organization: Usenet Volunteer Votetakers Lines: 125 Sender: [email protected] Approved: [email protected] Expires: 13 Jul 1995 00:00:00 GMT Message-ID: <[email protected]> References: <[email protected]> Reply-To: [email protected] NNTP-Posting-Host: rodan.uu.net Xref: gs2.UU.NET news.announce.newgroups:7077 news.groups:154650 sci.med:132685 sci.med.immunology:1864 alt.med.fibromyalgia:25373 alt.support.arthritis:4562 misc.health.arthritis:1930 bionet.microbiology:2566 sci.bio.microbiology:1137                            FIRST CALL FOR VOTES (of 2)                    unmoderated group sci.med.diseases.lyme  Newsgroups line: sci.med.diseases.lyme	Lyme Disease: patient support, research & information.  Votes must be received by 23:59:59 UTC, 12 July 1995.  This vote is being conducted by a neutral third party.  For voting questions only contact Warren Lavallee <[email protected]>.  For questions about the proposed group contact Linda Palund <[email protected]>.  DISTRIBUTION This CFV has been cross posted to:    sci.med, sci.med.immunology, alt.med.fibromyalgia,   alt.support.arthritis, misc.health.arthritis, bionet.microbiology,   sci.bio.microbiology  And EMailed to: 	LymeNet <[email protected]>  CHARTER          The proposed newsgroup, sci.med.diseases.lyme, is intended for discussion about the many different aspects of Lyme Disease as experienced by patients, their caregivers, friends and family members, doctors and other medical professionals, or anyone affected by or involved with Lyme Disease, as well as those who wish to learn about its symptoms, latest treatment options and its prevention.          Anyone with an interest in Lyme Disease is free to post, including the medical and scientific community, as this newsgroup is interested both in fostering communication between Lyme Disease sufferers from all parts of the globe, as well as providing an open forum for the exchange of medical and scientific information which can be useful to all participants. Above all, we wish to encourage a supportive and open atmosphere for the free exchange of opinions and information.  The following are examples of possible posting topics:  - questions regarding any aspect of Lyme Disease - symptoms and problems arising from the onset of new symptoms - treatments and therapies, both conventional and alternative - emotions, including fears and anxieties caused by this illness - social issues regarding this illness - problems in the medical community in regard to Lyme Disease - new information and resources available about the disease - related practical problems or solutions - Lyme Disease research findings  Commercial advertisements may NOT be posted to this proposed group.  LymeNet Mailing List will be gatewayed to sci.med.diseases.lyme  RATIONALE          There is currently no discussion group for the many persons suffering from or involved with Lyme Disease. The symptoms of Lyme Disease are as varied as the terrain in which the disease carrying tick thrives, and patients are often left isolated by their debilitating symptoms in quite rural locations. Although there are Lyme Disease support groups in various geographic locations, the severe limitations of the symptoms experienced by patients make it often impossible for them to physically attend these groups. This proposed newsgroup would give housebound patients a much needed forum to discuss the disease, as well as giving them the support they need. It will also enable researchers and doctors from all over the medical and scientific community who are studying this disease, to communicate via the Lyme Disease newsgroup and could be invaluable help in the dissemination of useful information to all persons concerned with Lyme Disease.   HOW TO VOTE  Send MAIL to:   [email protected] Just Replying should work if you are not reading this on a mailing list.  Your mail message should contain *one* and only one of the following statements.  DO NOT QUOTE THIS CFV IN YOUR VOTE.       I vote YES on sci.med.diseases.lyme       I vote NO on sci.med.diseases.lyme       I vote ABSTAIN on sci.med.diseases.lyme       I CANCEL my vote on sci.med.diseases.lyme  Neither ABSTAIN nor CANCEL messages are counted as votes; they serve only to cancel any previous vote. Abstentions are noted in the final vote list, whereas CANCEL removes your vote from that list entirely. (This is the only difference between the two.)  Anything else may be rejected by the automatic vote counting program.  The votetaker will respond to your received ballots with a personal acknowledge- ment by mail - if you do not receive one within several days, try again. It's your responsibility to make sure your vote is registered correctly.  If you later change your mind you may vote again; only your last valid vote will count.  Anonymous votes will not be accepted. Votes mailed by WWW/HTML/CGI forms are considered anonymous votes. (The vote must be mailed directly from the voter to the votetaker.)  In cases where voting fraud is determined to have occurred, it is standard operating procedure to delete ALL votes submitted by the violator.  If you give anyone a copy of the CFV, it must be whole and unmodified.  When in doubt, ask the votetaker.  Standard Guidelines for voting apply: no more than one vote per person, no more than one vote per account. If you attempt multiple votes or other vote fraud, all your votes may be canceled and your name published.  The complete vote list will be posted with the vote result, including how each person voted. Note that Usenet votes are not done by secret ballot.  There will then be a five-day period during which the published vote list may be corrected and any irregularities addressed. The requirements for group creation are 100 more YES votes than NO votes, and 2/3 of all counted votes being YES.  From [email protected] Tue Jul 11 13:28:22 1995 Status: RO Path: uunet!in1.uu.net!bounce-back From: [email protected] (Warren Lavallee) Newsgroups: news.announce.newgroups,news.groups,sci.med,sci.med.immunology,alt.med.fibromyalgia,alt.support.arthritis,misc.health.arthritis,bionet.microbiology,sci.bio.microbiology Subject: 2nd CFV: sci.med.diseases.lyme Followup-To: news.groups Date: 10 Jul 1995 18:18:46 -0400 Organization: Usenet Volunteer Votetakers Lines: 125 Sender: [email protected] Approved: [email protected] Expires: 13 Jul 1995 00:00:00 GMT Message-ID: <[email protected]> Reply-To: [email protected] NNTP-Posting-Host: rodan.uu.net Xref: gs2.UU.NET news.announce.newgroups:7107 news.groups:158576 sci.med:135050 sci.med.immunology:1963 alt.med.fibromyalgia:27089 alt.support.arthritis:5000 misc.health.arthritis:2126 bionet.microbiology:2694 sci.bio.microbiology:1216                            LAST CALL FOR VOTES (of 2)                    unmoderated group sci.med.diseases.lyme  Newsgroups line: sci.med.diseases.lyme	Lyme Disease: patient support, research & information.  Votes must be received by 23:59:59 UTC, 12 July 1995.  This vote is being conducted by a neutral third party.  For voting questions only contact Warren Lavallee <[email protected]>.  For questions about the proposed group contact Linda Palund <[email protected]>.  DISTRIBUTION This CFV has been cross posted to:    sci.med, sci.med.immunology, alt.med.fibromyalgia,   alt.support.arthritis, misc.health.arthritis, bionet.microbiology,   sci.bio.microbiology  And EMailed to: 	LymeNet <[email protected]>  CHARTER          The proposed newsgroup, sci.med.diseases.lyme, is intended for discussion about the many different aspects of Lyme Disease as experienced by patients, their caregivers, friends and family members, doctors and other medical professionals, or anyone affected by or involved with Lyme Disease, as well as those who wish to learn about its symptoms, latest treatment options and its prevention.          Anyone with an interest in Lyme Disease is free to post, including the medical and scientific community, as this newsgroup is interested both in fostering communication between Lyme Disease sufferers from all parts of the globe, as well as providing an open forum for the exchange of medical and scientific information which can be useful to all participants. Above all, we wish to encourage a supportive and open atmosphere for the free exchange of opinions and information.  The following are examples of possible posting topics:  - questions regarding any aspect of Lyme Disease - symptoms and problems arising from the onset of new symptoms - treatments and therapies, both conventional and alternative - emotions, including fears and anxieties caused by this illness - social issues regarding this illness - problems in the medical community in regard to Lyme Disease - new information and resources available about the disease - related practical problems or solutions - Lyme Disease research findings  Commercial advertisements may NOT be posted to this proposed group.  LymeNet Mailing List will be gatewayed to sci.med.diseases.lyme  RATIONALE          There is currently no discussion group for the many persons suffering from or involved with Lyme Disease. The symptoms of Lyme Disease are as varied as the terrain in which the disease carrying tick thrives, and patients are often left isolated by their debilitating symptoms in quite rural locations. Although there are Lyme Disease support groups in various geographic locations, the severe limitations of the symptoms experienced by patients make it often impossible for them to physically attend these groups. This proposed newsgroup would give housebound patients a much needed forum to discuss the disease, as well as giving them the support they need. It will also enable researchers and doctors from all over the medical and scientific community who are studying this disease, to communicate via the Lyme Disease newsgroup and could be invaluable help in the dissemination of useful information to all persons concerned with Lyme Disease.   HOW TO VOTE  Send MAIL to:   [email protected] Just Replying should work if you are not reading this on a mailing list.  Your mail message should contain *one* and only one of the following statements.  DO NOT QUOTE THIS CFV IN YOUR VOTE.       I vote YES on sci.med.diseases.lyme       I vote NO on sci.med.diseases.lyme       I vote ABSTAIN on sci.med.diseases.lyme       I CANCEL my vote on sci.med.diseases.lyme  Neither ABSTAIN nor CANCEL messages are counted as votes; they serve only to cancel any previous vote. Abstentions are noted in the final vote list, whereas CANCEL removes your vote from that list entirely. (This is the only difference between the two.)  Anything else may be rejected by the automatic vote counting program.  The votetaker will respond to your received ballots with a personal acknowledge- ment by mail - if you do not receive one within several days, try again. It's your responsibility to make sure your vote is registered correctly.  If you later change your mind you may vote again; only your last valid vote will count.  Anonymous votes will not be accepted. Votes mailed by WWW/HTML/CGI forms are considered anonymous votes. (The vote must be mailed directly from the voter to the votetaker.)  In cases where voting fraud is determined to have occurred, it is standard operating procedure to delete ALL votes submitted by the violator.  If you give anyone a copy of the CFV, it must be whole and unmodified.  When in doubt, ask the votetaker.  Standard Guidelines for voting apply: no more than one vote per person, no more than one vote per account. If you attempt multiple votes or other vote fraud, all your votes may be canceled and your name published.  The complete vote list will be posted with the vote result, including how each person voted. Note that Usenet votes are not done by secret ballot.  There will then be a five-day period during which the published vote list may be corrected and any irregularities addressed. The requirements for group creation are 100 more YES votes than NO votes, and 2/3 of all counted votes being YES.  From [email protected] Fri Jul 14 11:19:58 1995 Status: RO Path: uunet!in1.uu.net!bounce-back From: [email protected] (Warren Lavallee) Newsgroups: news.announce.newgroups,news.groups,sci.med,sci.med.immunology,alt.med.fibromyalgia,alt.support.arthritis,misc.health.arthritis,bionet.microbiology,sci.bio.microbiology Subject: RESULT: sci.med.diseases.lyme passes 131:13 Followup-To: news.groups Date: 13 Jul 1995 20:26:03 -0400 Organization: Usenet Volunteer Votetakers Lines: 237 Sender: [email protected] Approved: [email protected] Message-ID: <[email protected]> NNTP-Posting-Host: rodan.uu.net Xref: gs2.UU.NET news.announce.newgroups:7155 news.groups:159392 sci.med:135523 sci.med.immunology:1977 alt.med.fibromyalgia:27383 alt.support.arthritis:5058 misc.health.arthritis:2150 bionet.microbiology:2724 sci.bio.microbiology:1242                                  RESULT             unmoderated group sci.med.diseases.lyme passes 131:13  There were 131 YES votes and 13 NO votes, for a total of 144 valid votes. There were 4 abstains and 8 invalid ballots.  For group passage, YES votes must be at least 2/3 of all valid (YES and NO) votes.   There also must be at least 100 more YES votes than NO votes.  There is a five day discussion period after these results are posted.  If no serious allegations of voting irregularities are raised, the moderator of news.announce.newgroups will create the group shortly thereafter.    sci.med.diseases.lyme passed on Tue Jul 4 15:29:53 1995  Newsgroups line: sci.med.diseases.lyme	Lyme Disease: patient support, research & information.  This vote was being conducted by a neutral third party. For voting questions only contact Warren Lavallee <[email protected]>. For questions about the proposed group contact Linda Palund <[email protected]>.  CHARTER          The proposed newsgroup, sci.med.diseases.lyme, is intended for discussion about the many different aspects of Lyme Disease as experienced by patients, their caregivers, friends and family members, doctors and other medical professionals, or anyone affected by or involved with Lyme Disease, as well as those who wish to learn about its symptoms, latest treatment options and its prevention.          Anyone with an interest in Lyme Disease is free to post, including the medical and scientific community, as this newsgroup is interested both in fostering communication between Lyme Disease sufferers from all parts of the globe, as well as providing an open forum for the exchange of medical and scientific information which can be useful to all participants. Above all, we wish to encourage a supportive and open atmosphere for the free exchange of opinions and information.  The following are examples of possible posting topics:  - questions regarding any aspect of Lyme Disease - symptoms and problems arising from the onset of new symptoms - treatments and therapies, both conventional and alternative - emotions, including fears and anxieties caused by this illness - social issues regarding this illness - problems in the medical community in regard to Lyme Disease - new information and resources available about the disease - related practical problems or solutions - Lyme Disease research findings  Commercial advertisements may NOT be posted to this proposed group.  LymeNet Mailing List will be gatewayed to sci.med.diseases.lyme  [This collection of addresses is (C)1995 by Consultix Computer Services. Permission is strictly NOT given to use this list or any part thereof to make a mailing list, or for mass-mailings.  Any other use is fine.] sci.med.diseases.lyme Final Vote Ack  Voted Yes ------------------------------------------------------------------------------ [email protected]                                           Jonathan Adair [email protected]                                                   Andrew Hall [email protected]                                                 Aimee Phillpot [email protected]                                                 Tina M. Wood [email protected] [email protected]                                    George Armhold [email protected]                           Amittai F. Aviram [email protected]                                           Ed Bailey [email protected] [email protected]                                                   beth kaimowitz [email protected]                                 Douglas P. Shannon [email protected]                                      Carol J. Botteron [email protected] [email protected]                                             Ben Parker [email protected]                                            Brian Klinkenberg [email protected] [email protected]                    Christine Gilmore Eubanks [email protected]                                                  Chicago [email protected]                                         Chris Stamper [email protected]                                        Catherine Nelson [email protected]                                       Chris Newport [email protected]                                           Colman M. Jones [email protected]                                           David Croft [email protected] [email protected]                                               Darek Iwanski [email protected] [email protected] [email protected]                                            Dean Jenkins [email protected]                                                 Dick Manley [email protected]                                          Doug Murphy [email protected]                                            Donna Herrell [email protected]                                                         Ryan [email protected]                                                            effie [email protected]                                     Eugene N. Miya [email protected]                                              Bruce Giese [email protected]                                      Benedict A. Gomes [email protected]                                        Pat Gonzales [email protected]                                                     ZmG [email protected]                                                 Dick Grady [email protected]                                                    Kiran Wagle [email protected]                                               George W. Baltz [email protected]                                   David Hampson [email protected]                                                   Hal Blatman [email protected] HIRSCHBERG#m#[email protected]     Marvin Hirschberg (216)433-3206 [email protected]                                           Jane Wong [email protected]                                                Dr Iain G. Old [email protected] [email protected]                                        Janet Kowalewski [email protected]                                             James M. Byers [email protected] [email protected]                          Joyce A Knauerhase [email protected] [email protected] [email protected] [email protected]                                               Mike Lake [email protected]                                           John Setel O'Donnell [email protected]                                           Joel Hornstein [email protected]                                                       Jim Olsen [email protected]                                                           Jonboy [email protected]                                        Sudish Joseph [email protected]                                       Joy Veronneau [email protected] [email protected]                                       John R. Sherlock [email protected]                                               John Lester [email protected]               Karl-Heinz Kuhn t2150 [email protected]                                          KATHY L. BIRDWELL [email protected]                                            Ken Descoteaux [email protected]                               Kimmo Ketolainen +358 40 500 2957 [email protected]                                       Rob Knauerhase [email protected]                                                 Trisha Benedict [email protected]                                        Claude Lapointe (ACISD) [email protected]                                  Martin Schr"oder [email protected]                                                  Les Thomas [email protected]                                        Madelaine Davidson [email protected]                                              Michael A. Chary [email protected]                                              Marc Dashevsky [email protected] [email protected]                                    Mitch Collinsworth [email protected]                                             Linda Palund [email protected]                                                 Robert K. Moore [email protected]                                          Michael Ricci [email protected]                                     Omer Nirhod [email protected]                                  Marlene J. Stern [email protected]                                                     Nigel Allen [email protected]                                                   Nelia Lyda [email protected]                           North Haven High School [email protected]                                          Nick Ingegneri [email protected]                                           Norman Birkett [email protected] [email protected]                                            Philip Decker [email protected]                                           Peter Rohleder [email protected]                                      John Pimentel [email protected]                                            Jim DePietro [email protected] [email protected] [email protected]                                              Rebecca Drayer [email protected]                                             R.S.LITTLE [email protected]                         RALPH W. CONNELL - LGSPI [email protected]                                               Rebecca Otis [email protected] [email protected] [email protected]                                     Ruth Ginzberg [email protected]                                                          RGyure [email protected]                                             Richard H. Miller [email protected]                                  Robert M. Levy [email protected] [email protected]                            Roger Marshall [email protected]                                                    R. S. Camm [email protected]                                             Robert Smits [email protected]                                       Jeffrey Rufinus [email protected]                                           David Revitt [email protected]                                                      shells [email protected]                                      timothy shimeall [email protected]                                        Schuyler W Horton [email protected]                                                    Gil Singer [email protected]                                                 Linda W. White [email protected]                                                     Boudicca stonesifer#m#[email protected]                      Stonesifer, Phyllis [email protected]                                                      Steve Roberts [email protected]                                             s rich [email protected]                                             Barnet Sherman [email protected]                                                 Coralie J. Allen [email protected]                                      Patti Telegan [email protected]                                            Thomas G. McWilliams [email protected] [email protected]                                             T. Singer [email protected]                                        Tim Pierce [email protected]                               Abdul W Abdul [email protected]                                                Ulf Garpmo [email protected]                                      Ulf Bahrenfuss  Voted No ------------------------------------------------------------------------------ [email protected]                                        Andrew H. Marrinson [email protected]                                          Anita Kilgour [email protected]                                                   Balaji [email protected]                                               Michiel Wijers [email protected]                                                         Ed Anderson [email protected]                                                Edward Reid [email protected]                                                   Emery Lapinski [email protected]                                                     HiTech [email protected]                                                  Joel B Levin [email protected]                                           Kam Shojania, MD [email protected]                                         Smarasderagd [email protected]                                                  Dwight Brown [email protected]                                         Risto Widenius  Abstained ------------------------------------------------------------------------------ [email protected]                              Kenneth P Crouch [email protected]                  Edward McSweegan [email protected]                                       Taneli Huuskonen [email protected]                                          M Mike Taksar KC6ZPS   Votes in error ------------------------------------------------------------------------------ [email protected]                                        Camilla Cracchiolo    ! No vote statement in message [email protected]                                                  ewinner    ! No vote statement in message [email protected]                                            Ivar van Heijningen    ! No vote statement in message [email protected]                                         Johanna Lynch    ! No vote statement in message [email protected]                                               Michael J. Reeves    ! No vote statement in message [email protected]                                    NEWS News Admin.    ! Invalid address [email protected]                                         Robert M. Evans    ! No vote statement in message [email protected]                               Vladimir A. Bolibok    ! Invalid address  
 
USENET FACT: Flaming
Flaming is the hostile interaction between multiple Usenet users.
 
Menu